SAN FRANCISCO, Oct. 17, 2016 -- Hagens Berman Sobol Shapiro LLP reminds investors in Goldcorp, Inc. (NYSE:GG) of the October 24, 2016 Lead Plaintiff deadline in the securities class action lawsuit filed in the United States District Court for the Central District of California.
If you purchased or otherwise acquired securities of Goldcorp, Inc. between March 31, 2014 and August 24, 2016 and suffered significant losses contact Hagens Berman Sobol Shapiro LLP. For more information visit:
https://www.hbsslaw.com/cases/GG
or contact Reed Kathrein, who is leading the firm’s investigation, by calling 510-725-3000 or emailing [email protected].
Reuters reported on August 24, 2016 that Goldcorp, Inc. potentially violated Mexican regulations by failing to remedy selenium contamination in ground water caused by the Company’s Penasquito Mine.
According to the World Health Organization and the U.S. Department of Health & Human Services’ National Institutes of Health (“NIH”), dangers to humans from excessive exposure to selenium can include difficulty breathing, tremors, kidney failure, heart attacks, and heart failure.
Goldcorp allegedly never disclosed the contamination issues to the public, instead reporting in its SEC filings during the relevant period that it properly carried out all “mining and processing operations and exploration and development activities” pursuant to applicable laws.
In response to the Reuters report, the price of Goldcorp securities fell over 9% to close at $15.95 on August 26, 2016.
On September 26, 2016, landowners and truck drivers in the region blockaded the Penasquito mine, apparently in protest of Goldcorp’s operations. On October 7, 2016, Goldcorp announced removal of the blockade and the ramp up of further mining.
“Goldcorp’s Penasquito Mine operations were a significant business,” said Hagens Berman partner Reed Kathrein. “The Company’s undisclosed facts were important for investors to know when deciding whether to invest.”
Whistleblowers: Persons with non-public information regarding Goldcorp, Inc. should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new SEC whistleblower program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 510-725-3000 or email [email protected].
About Hagens Berman
Hagens Berman is a national investor-rights law firm headquartered in Seattle, Washington with offices in 10 cities. The Firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the Firm and its successes can be found at www.hbsslaw.com. Read the Firm’s Securities Newsletter, and visit the blog. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.
Contact: Reed Kathrein, 510-725-3000


Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing 



